Ikarian Capital, LLC Bristol Myers Squibb CO Transaction History

Ikarian Capital, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$59.34 - $66.74 $17.1 Million - $19.2 Million	-288,400 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$57.74 - $65.43 $10.9 Million - $12.3 Million	188,400 Added 188.4%	288,400 $17.9 Million
Q3 2020 Nov 16, 2020	BUY	$57.43 - $63.64 $5.74 Million - $6.36 Million	100,000 New	100,000 $6.03 Million

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $120B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.